STERIS (STE) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
1 Dec, 2025Voting matters and shareholder proposals
Shareholders will vote on the re-election of ten directors at the annual meeting on August 1, 2024.
Proposals include ratifying Ernst & Young LLP as the independent registered public accounting firm for the fiscal year ending March 31, 2025.
Appointment and remuneration of Ernst & Young Chartered Accountants as statutory auditor under Irish law are up for approval.
Advisory vote on executive compensation, including the compensation discussion and analysis, is included.
Proposals to renew the Board's authority to issue shares and opt-out of statutory pre-emption rights under Irish law will be considered.
Board of directors and corporate governance
Ten director nominees are presented for re-election, reflecting a diverse and experienced board.
The Board recommends voting in favor of all director nominees and proposals.
Executive compensation and say-on-pay
Shareholders will cast a non-binding advisory vote on the compensation of named executive officers as disclosed in the proxy statement.
Latest events from STERIS
- Q3 revenue and EPS up 9%, outlook steady despite tariff and Q4 headwinds.STE
Q3 20266 Feb 2026 - Revenue up 8.1% to $1.28B, adjusted EPS at $2.03, and full-year outlook reaffirmed.STE
Q1 20252 Feb 2026 - Strong U.S. healthcare volumes and recurring revenue drive growth amid evolving global trends.STE
Morgan Stanley 22nd Annual Global Healthcare Conference22 Jan 2026 - Q2 revenue up 7.3% and adjusted EPS at $2.14; FY25 outlook reaffirmed.STE
Q2 202515 Jan 2026 - Q3 revenue up 6% and adjusted EPS rises to $2.32; outlook narrowed on currency headwinds.STE
Q3 20258 Jan 2026 - Shareholders to vote on director re-elections, auditor appointments, and executive pay amid strong growth.STE
Proxy Filing1 Dec 2025 - Shareholders to vote on key governance, compensation, and capital proposals after a year of strong growth.STE
Proxy Filing1 Dec 2025 - Dr. Steeves retires from the board; all other proxy items and nominees remain unchanged.STE
Proxy Filing1 Dec 2025 - Director elections, auditor ratification, and executive pay up for vote at July 2025 AGM.STE
Proxy Filing1 Dec 2025